Ep. 474: Frankly Speaking: How to Invest in small-cap biotech stocks

Wall Street Unplugged - What's Really Moving These Markets

Frank Curzio

Business, News, Commodities, Debt, Investing, Macroeconomics, Gold, Personal, Uranium, Oil, Economics, Business News, Geopolitics, Industry, Crypto, Stocks, Curzio, Trading, Finance, Research, Investments, Tokens, Talk, Crisis

4.5 • 1.1K Ratings

🗓️ 17 December 2016

⏱️ 48 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Welcome back to another episode of Frankly Speaking! Special thanks to Brain, Jeff, Kenny, Craig, and Steve for all the great questions. On today's show, I open up by breaking down the small-cap biotech sector. Jeff provides listeners with a perfect example of a biotech stock fighting for FDA approval. I've seen this happen too many times... From the pre-clinical stages... all the way through the approval process... these companies undertake extreme volatility. Step-by-step, I explain the lengthy process every small-cap biotech company must endure. In addition, I tell listeners exactly when it's the best time to place their bets on these types of investments. Then, after revisiting my position on Northern Dynasty (NAK), I dive into a very important lesson... Stop-loss orders. This is an investment tool every investor must use in order to prevent large portfolio deficits. I often warn investors to not "show their hand"... Tune in to hear what I mean. Finally, to end the episode, I dive into another sector that has just about topped-out. With interest rates going higher, I tell listeners why I'm avoiding this market going forward. Other stocks mentioned include: Pfizer (PFE), Merck (MRK), Amgen (AMGN), & TherapeuticsMD (TXMD) Thanks for listening, Frank Curzio

Transcript

Click on a timestamp to play from that location

0:00.0	Wall Street Unplugged looks beyond the regular headlines heard on mainstream
0:06.0	financial media to bring you unscripted interviews and breaking commentary direct from Wall Street
0:11.8	right to you on Main Street.
0:14.0	We're going out there, it's Friday, December 16th.
0:18.0	I'm Frank Curzier hosted the Frankly Speaking Podcast
0:21.0	where I answer all of your questions about the market stocks
0:23.6	economy sports and anything else you want to throw at me I create this podcast
0:28.4	to answer more of your questions that you was sending me through my Wall Street
0:30.8	unplugged podcast which I host every single Wednesday.
0:33.7	Do you have any questions you want answered?
0:35.9	Just send me an email at Frank at cursier research.com.
0:39.1	That's Frank at cursier research.
0:40.8	com.
0:41.5	Be sure to put frankly speaking in the headline, and you never know,
0:45.6	your question may be the one I read on this podcast. Keep those questions coming in,
0:50.8	boots on the ground, awesome stuff. Let's start, the question from
0:55.4	Brian. This great podcast Frank came across it because Marron Katusa posted a
1:00.4	link on Twitter early in the year. As an online merchant, this has been my best
1:04.9	Christmas season in quite some time. My question. I was curious if you had any advice on investing in
1:11.0	micro a nanom cap stocks stocks outside the resource sector.
1:15.0	With Canadian juniors, I was always able to find great info utilizing the SEDI or CEDAW.
1:22.0	Just knowing what a Ross Beatty or Rob McEwing a report... utilizing the SEDI or CEDAWER.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Frank Curzio, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Frank Curzio and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.